Certain biomarkers, such as high-sensitivity C-reactive protein (hs-CRP) and Hemoglobin A1c (HbA1c), also called glycated hemoglobin, have demonstrated their ability to forecast cardiovascular diseases (CVDs) in people with DM [7]. This evidence concerns the gene CRP and diabetes mellitus.